| 0 |
DISEASE PROGRESSION |
80 |
| 1 |
OFF LABEL USE |
26 |
| 2 |
MALIGNANT NEOPLASM PROGRESSION |
25 |
| 3 |
ANAEMIA |
21 |
| 4 |
THROMBOCYTOPENIA |
21 |
| 5 |
LYMPHADENOPATHY |
19 |
| 6 |
PNEUMONIA |
12 |
| 7 |
DECREASED APPETITE |
10 |
| 8 |
RICHTER^S SYNDROME |
10 |
| 9 |
DEATH |
9 |
| 10 |
PYREXIA |
9 |
| 11 |
HYPONATRAEMIA |
8 |
| 12 |
NEUTROPHIL COUNT DECREASED |
7 |
| 13 |
C-REACTIVE PROTEIN INCREASED |
6 |
| 14 |
INFUSION RELATED REACTION |
6 |
| 15 |
NAUSEA |
6 |
| 16 |
RENAL IMPAIRMENT |
6 |
| 17 |
FEBRILE NEUTROPENIA |
5 |
| 18 |
MYELOSUPPRESSION |
5 |
| 19 |
NEUROPATHY PERIPHERAL |
5 |
| 20 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
| 21 |
HYPOTHYROIDISM |
4 |
| 22 |
INTERSTITIAL LUNG DISEASE |
4 |
| 23 |
MALAISE |
4 |
| 24 |
METASTASES TO LIVER |
4 |
| 25 |
STOMATITIS |
4 |
| 26 |
TUMOUR PERFORATION |
4 |
| 27 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
| 28 |
ANAPHYLACTIC SHOCK |
3 |
| 29 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
| 30 |
DIARRHOEA |
3 |
| 31 |
DRUG INEFFECTIVE |
3 |
| 32 |
ENTEROCOLITIS |
3 |
| 33 |
FALL |
3 |
| 34 |
HEPATIC FUNCTION ABNORMAL |
3 |
| 35 |
INFECTION |
3 |
| 36 |
METASTASES TO LUNG |
3 |
| 37 |
VOMITING |
3 |
| 38 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
| 39 |
ACUTE KIDNEY INJURY |
2 |
| 40 |
ADRENAL INSUFFICIENCY |
2 |
| 41 |
ALOPECIA |
2 |
| 42 |
ASTHENIA |
2 |
| 43 |
BRADYCARDIA |
2 |
| 44 |
CARDIAC ARREST |
2 |
| 45 |
CARDIAC FAILURE |
2 |
| 46 |
CHILLS |
2 |
| 47 |
DIABETIC NEUROPATHY |
2 |
| 48 |
FEMORAL NECK FRACTURE |
2 |
| 49 |
HEADACHE |
2 |
| 50 |
HEPATITIS |
2 |
| 51 |
HEPATOTOXICITY |
2 |
| 52 |
HYPERGLYCAEMIA |
2 |
| 53 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
2 |
| 54 |
LEUKOPENIA |
2 |
| 55 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
| 56 |
METASTASES TO LYMPH NODES |
2 |
| 57 |
NEUTROPENIA |
2 |
| 58 |
NEUTROPENIC SEPSIS |
2 |
| 59 |
PERFORMANCE STATUS DECREASED |
2 |
| 60 |
PERICARDIAL EFFUSION |
2 |
| 61 |
PLATELET COUNT DECREASED |
2 |
| 62 |
PNEUMONIA ASPIRATION |
2 |
| 63 |
POLYNEUROPATHY |
2 |
| 64 |
RASH |
2 |
| 65 |
RESPIRATORY FAILURE |
2 |
| 66 |
STEVENS-JOHNSON SYNDROME |
2 |
| 67 |
THERAPEUTIC RESPONSE DECREASED |
2 |
| 68 |
ADRENAL DISORDER |
1 |
| 69 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
| 70 |
ANAPHYLACTIC REACTION |
1 |
| 71 |
APPENDICITIS PERFORATED |
1 |
| 72 |
ASCITES |
1 |
| 73 |
ATRIAL TACHYCARDIA |
1 |
| 74 |
CARDIAC DISORDER |
1 |
| 75 |
CARDIAC TAMPONADE |
1 |
| 76 |
CAROTID ARTERY STENOSIS |
1 |
| 77 |
CEREBRAL INFARCTION |
1 |
| 78 |
CEREBROVASCULAR ACCIDENT |
1 |
| 79 |
CHEST PAIN |
1 |
| 80 |
CHOLANGITIS |
1 |
| 81 |
CHOLESTASIS |
1 |
| 82 |
CONDITION AGGRAVATED |
1 |
| 83 |
COVID-19 |
1 |
| 84 |
CYSTITIS |
1 |
| 85 |
CYTOKINE RELEASE SYNDROME |
1 |
| 86 |
CYTOMEGALOVIRUS ENTERITIS |
1 |
| 87 |
CYTOPENIA |
1 |
| 88 |
DEAFNESS |
1 |
| 89 |
DEHYDRATION |
1 |
| 90 |
DERMATITIS |
1 |
| 91 |
DEVICE RELATED INFECTION |
1 |
| 92 |
DIZZINESS |
1 |
| 93 |
DRUG HYPERSENSITIVITY |
1 |
| 94 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
| 95 |
DUODENAL ULCER HAEMORRHAGE |
1 |
| 96 |
DYSPHAGIA |
1 |
| 97 |
DYSPNOEA |
1 |
| 98 |
ENZYME LEVEL INCREASED |
1 |
| 99 |
FATIGUE |
1 |
| 100 |
FEEDING DISORDER |
1 |
| 101 |
GASTROINTESTINAL STENOSIS |
1 |
| 102 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 103 |
GYNAECOMASTIA |
1 |
| 104 |
HAEMATOCHEZIA |
1 |
| 105 |
HEPATIC FAILURE |
1 |
| 106 |
HEPATITIS ACUTE |
1 |
| 107 |
HIP FRACTURE |
1 |
| 108 |
HYPERAMMONAEMIA |
1 |
| 109 |
HYPERSENSITIVITY |
1 |
| 110 |
HYPERTRIGLYCERIDAEMIA |
1 |
| 111 |
HYPERVOLAEMIA |
1 |
| 112 |
HYPOAESTHESIA |
1 |
| 113 |
HYPOKALAEMIA |
1 |
| 114 |
ILEUS PARALYTIC |
1 |
| 115 |
IMMUNE-MEDIATED ENCEPHALITIS |
1 |
| 116 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
| 117 |
IMMUNE-MEDIATED THYROIDITIS |
1 |
| 118 |
IMMUNOSUPPRESSION |
1 |
| 119 |
INFLAMMATION |
1 |
| 120 |
LICHEN PLANUS |
1 |
| 121 |
LIVER FUNCTION TEST ABNORMAL |
1 |
| 122 |
LOSS OF CONSCIOUSNESS |
1 |
| 123 |
LUNG DISORDER |
1 |
| 124 |
LUNG NEOPLASM |
1 |
| 125 |
LYMPHOMA |
1 |
| 126 |
MEDIASTINITIS |
1 |
| 127 |
MEDICAL DEVICE SITE INFECTION |
1 |
| 128 |
MELAENA |
1 |
| 129 |
MENTAL DISORDER |
1 |
| 130 |
METASTASES TO BONE |
1 |
| 131 |
METASTASES TO CHEST WALL |
1 |
| 132 |
MOUTH BREATHING |
1 |
| 133 |
MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME |
1 |
| 134 |
NEOPLASM PROGRESSION |
1 |
| 135 |
OESOPHAGEAL CARCINOMA |
1 |
| 136 |
OESOPHAGEAL PERFORATION |
1 |
| 137 |
OESOPHAGEAL WALL HYPERTROPHY |
1 |
| 138 |
PAIN |
1 |
| 139 |
PANCREATITIS |
1 |
| 140 |
PERFORATION |
1 |
| 141 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
1 |
| 142 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
| 143 |
PORTAL VENOUS GAS |
1 |
| 144 |
PROCALCITONIN INCREASED |
1 |
| 145 |
PRURITUS |
1 |
| 146 |
PULMONARY EMBOLISM |
1 |
| 147 |
PULMONARY SEPSIS |
1 |
| 148 |
PULMONARY TOXICITY |
1 |
| 149 |
PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY |
1 |
| 150 |
RASH PRURITIC |
1 |
| 151 |
RASH VESICULAR |
1 |
| 152 |
SEIZURE |
1 |
| 153 |
SEPSIS |
1 |
| 154 |
SHOCK |
1 |
| 155 |
SKIN DISORDER |
1 |
| 156 |
SURGERY |
1 |
| 157 |
SYNCOPE |
1 |
| 158 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 159 |
TOXIC ENCEPHALOPATHY |
1 |
| 160 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
| 161 |
TRACHEAL FISTULA |
1 |
| 162 |
TREATMENT FAILURE |
1 |
| 163 |
TUMOUR RUPTURE |
1 |
| 164 |
TYPE IV HYPERSENSITIVITY REACTION |
1 |
| 165 |
UNDERDOSE |
1 |
| 166 |
VASCULITIS |
1 |
| 167 |
VASCULITIS GASTROINTESTINAL |
1 |
| 168 |
WEIGHT DECREASED |
1 |
| 169 |
WITHDRAWAL SYNDROME |
1 |